Patient-Derived PSEN1 Cerebral Organoids Revealed Parallel Development of Amyloid-β Accumulation and Network Dysfunction
Authors:
- Andrijana AngelovskiAAAndrijana Angelovski
- Hana HribkovaHHHana Hribkova
- Jiri SedmikJSJiri Sedmik
- Barbora LiscakovaBLBarbora Liscakova
- Olga SvecovaOSOlga Svecova
- Sona CesnarikovaSCSona Cesnarikova
- Katerina Amruz CernaKCKaterina Amruz Cerna
- Veronika PospisilovaVPVeronika Pospisilova
- Martin KralMKMartin Kral
- Martina KolajovaMKMartina Kolajova
- Petr KlimesPKPetr Klimes
- Dasa BohaciakovaDBDasa Bohaciakova
Open Access
- 20 July 2026
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 46 (1)
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by progressive dementia, brain atrophy, and ultimately death. Using cerebral organoids derived from human-induced pluripotent stem cells (hiPSCs) carrying the familial PSEN1 A246E variant, we investigated the temporal relationship between amyloid-β (Aβ) dysregulation and spontaneous neuronal activity. Multielectrode array recordings from the differentiation day 60 (DD60) to at least DD130 revealed that AD organoids exhibited transient hyperexcitability and hypersynchrony compared with wild-type (WT) controls, followed by a gradual decline in activity. During the enhanced excitability stage, both elevated Aβ42/40 and Aβ aggregate size showed positive correlations with the percentage of active electrodes and the global synchrony index (GSI) in AD organoids. These findings indicate that Aβ dysregulation might contribute to transient network hyperexcitability in early AD. The results also suggest that patient-derived cerebral organoids may serve as a translational model to examine early network dysfunction and inform future investigations of potential Aβ-induced changes in excitability during the preclinical stages of AD.Keywords
Funding Information
- Masaryk University
This publication has 55 references indexed in Scilit:
- Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET ClocksAnnals of Neurology, 2025
- Cerebral organoids derived from patients with Alzheimer’s disease with PSEN1/2 mutations have defective tissue patterning and altered developmentCell Reports, 2023
- Recent Advances in Electrophysiological Recording Platforms for Brain and Heart OrganoidsAdvanced NanoBiomed Research, 2022
- A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transferCell Reports Methods, 2022
- Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanismsBioengineering & Translational Medicine, 2022
- Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral OrganoidsStem Cell Reviews and Reports, 2022
- Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureAdvanced Science, 2021
- Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell NeurogenesisCell Reports, 2021
- Dynamic Changes in Neural Circuit Topology Following Mild Mechanical Injury In VitroAnnals of Biomedical Engineering, 2011
- Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channelsEpilepsy Research, 2011